Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Male cells need DHT to respond to testosterone, while female cells do not.

The inhibitor DPP can promote hair growth.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Differences in enzyme activity and androgen receptors in hair follicles may explain why hair loss appears differently in men and women.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Androgens don't directly affect hair cell growth or protein production.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Four-amino acid part makes enzyme sensitive to finasteride.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

MK-386 lowers DHT in blood and skin but not in semen.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Type 2 5α-reductase plays a key role in hair loss.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.